SCHAPIRO MARY L has filed 5 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 2155 shares of MORGAN STANLEY ($MS) on June 01, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 1, 2025 | MORGAN STANLEY | $MS | SCHAPIRO MARY L | Director | A | Common Stock | 2155 | $0.00 | 39,196.1910 | 1,611,000,000 | 5.82% | 0.00% |
| June 1, 2025 | MORGAN STANLEY | $MS | SCHAPIRO MARY L | Director | A | Common Stock | 451 | $127.58 | 39,646.8770 | 1,611,000,000 | 1.15% | 0.00% |
| Dec. 1, 2024 | MORGAN STANLEY | $MS | SCHAPIRO MARY L | Director | A | Common Stock | 379 | $132.04 | 36,581.5950 | 1,612,000,000 | 1.05% | 0.00% |
| Nov. 21, 2024 | CVS HEALTH Corp | $CVS | SCHAPIRO MARY L | Director | A | Deferred Stock Units | 2933 | $57.10 | 24,436.9156 | 1,262,000,000 | 13.64% | 0.00% |
| May 16, 2024 | CVS HEALTH Corp | $CVS | SCHAPIRO MARY L | Director | A | Share Credits | 2912 | $57.52 | 21,017.4328 | 1,290,000,000 | 16.08% | 0.00% |